Nanotechnology platform gets $7 million for commercial release
BioWorld - 24-Nov-2020Platform is designed to help pharmaceutical companies detect substances efficiently
Join the club for FREE to access the whole archive and other member benefits.
Next-gen instruments for quantitative protein measurement
Correlia Biosystems creates proteomic tools to power data-driven biology. Our instruments offer microsample measurement abilities to open new data for applications such as small animal models and precision medicine. Correlia’s automated tools can measure proteins with unparalleled speed and efficiency.
We enable researchers and clinicians to access proteomic information while reducing the cost and time to market for candidate therapeutics.
Visit website: https://correliabio.com/
Details last updated 17-Mar-2024
Platform is designed to help pharmaceutical companies detect substances efficiently